Blair William & Co. IL Acquires 3,594 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH)

Blair William & Co. IL boosted its stake in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) by 4.4% in the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 84,477 shares of the company’s stock after acquiring an additional 3,594 shares during the period. Blair William & Co. IL owned 0.17% of Prestige Consumer Healthcare worth $5,816,000 at the end of the most recent quarter.

Several other large investors have also recently made changes to their positions in the company. Mercer Global Advisors Inc. ADV increased its stake in Prestige Consumer Healthcare by 6.7% during the second quarter. Mercer Global Advisors Inc. ADV now owns 5,969 shares of the company’s stock worth $411,000 after acquiring an additional 374 shares during the last quarter. Renaissance Technologies LLC lifted its holdings in Prestige Consumer Healthcare by 4.2% during the 2nd quarter. Renaissance Technologies LLC now owns 373,802 shares of the company’s stock valued at $25,736,000 after buying an additional 15,100 shares in the last quarter. Kestrel Investment Management Corp bought a new stake in shares of Prestige Consumer Healthcare during the second quarter valued at approximately $2,504,000. Oak Associates Ltd. OH lifted its holdings in shares of Prestige Consumer Healthcare by 1.7% in the 2nd quarter. Oak Associates Ltd. OH now owns 14,555 shares of the company’s stock worth $1,002,000 after buying an additional 248 shares during the period. Finally, Envestnet Asset Management Inc. grew its holdings in Prestige Consumer Healthcare by 14.9% during the 2nd quarter. Envestnet Asset Management Inc. now owns 67,814 shares of the company’s stock worth $4,669,000 after acquiring an additional 8,782 shares in the last quarter. 99.95% of the stock is owned by institutional investors.

Analyst Ratings Changes

Separately, DA Davidson boosted their price target on Prestige Consumer Healthcare from $93.00 to $95.00 and gave the stock a “buy” rating in a research report on Wednesday, August 28th. One investment analyst has rated the stock with a hold rating and four have issued a buy rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $98.75.

Prestige Consumer Healthcare Price Performance

Shares of PBH stock opened at $73.03 on Friday. The firm has a market capitalization of $3.63 billion, a price-to-earnings ratio of 17.51, a PEG ratio of 2.08 and a beta of 0.48. Prestige Consumer Healthcare Inc. has a fifty-two week low of $56.34 and a fifty-two week high of $75.80. The company has a debt-to-equity ratio of 0.65, a quick ratio of 1.90 and a current ratio of 3.23. The stock’s 50-day simple moving average is $71.22 and its 200-day simple moving average is $69.66.

Prestige Consumer Healthcare (NYSE:PBH) last issued its earnings results on Thursday, August 8th. The company reported $0.90 EPS for the quarter, beating analysts’ consensus estimates of $0.86 by $0.04. The firm had revenue of $267.10 million for the quarter, compared to analyst estimates of $260.54 million. Prestige Consumer Healthcare had a return on equity of 12.55% and a net margin of 18.43%. Prestige Consumer Healthcare’s revenue for the quarter was down 4.4% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.06 earnings per share. As a group, equities analysts forecast that Prestige Consumer Healthcare Inc. will post 4.42 earnings per share for the current fiscal year.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.